Cannabis oil: all its advantages

Could CBD work in the battle against resistant bacterial stress? The results from the University of Queensland in Australia suggest that it is possible. However prior to examining the research study in depth, it is useful to understand the evolution of the relationship in between bacteria and antibiotics.

Since the revolutionary discovery of penicillin by Alexander Fleming in 1928, antibiotics have been an important tool in the battle against bacteria and infections. And although we still use the exact same tested techniques today, bacteria have developed. When exposed to antibiotics, specific bacteria, fungi and parasites have the ability to adapt and cancel the effectiveness of the drug by developing resistance.

It’s worth pointing out that antimicrobial resistance was most likely to take place anyhow, as the genetic code for bacteria changes with time. Nevertheless, it is thought that the overuse of antibiotics is an essential aspect that speeds up the development of resistant stress.

According to the World Health Organization, antimicrobial resistance “is a progressively serious hazard to global public health that requires action in all sectors of federal government and in society.” This has actually led researchers to think outside the box by trying to determine substances that could be beneficial in the battle against harmful bacteria. Among these substances is cannabidiol (CBD), a cannabinoid discovered in Cannabis sativa.

Scientists are looking for brand-new methods to assault infections and resistant bacteria.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD works against Gram-positive bacteria. Strains of Gram-positive bacteria consist of Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia).

Dr. Blaskovich presented his findings at a yearly conference of the American Society for Microbiology. In vitro samples of both kinds of gram-positive bacteria were treated with artificial CBD. The outcomes led Dr. Blaskovich to the conclusion that CBD works at levels similar to those of prescription antibiotics vancomycin and daptomycin. He likewise discovered that CBD appeared to work against gram-positive stress of resistant bacteria, which many conventional antibiotics are starting to fail.

” In specific, the activity was chosen against the resistant stress of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low tendency to cause resistance and was active against MRSA biofilms. “

The group likewise performed another research study using topical CBD to treat a skin infection in mice. Again, although the outcomes were positive, CBD did not appear to remove the infection, but just to decrease the number of bacterial cells.

Could CBD end up being an antibiotic?

While it is simple to hail this work as a substantial advancement in the anti-bacterial capabilities of CBD, it is too soon to give up on penicillin.

Although it is thought that the effectiveness of CBD oceanic could come from the method it assaults the biofilm surrounding bacterial cells, the authors are still uncertain of the mechanism of action of CBD. They likewise did not be reluctant to explain the drawbacks of the research study. Dr. Blaskovich explained that because the outcomes are in the preliminary phases, it is far prematurely for individuals to start treating their CBD infections themselves.

The research study was likewise performed in vitro (outside the human body), and there is a risk that the outcomes of medical trials will not be the same. Several substances have shown anti-bacterial efficacy in petri meals, but then failed at this vital stage. It ought to likewise be mentioned that the two research studies were carried out in cooperation with Botanix Pharmaceuticals Ltd, a pharmaceutical company specializing in topical CBD products.

Nevertheless, this research study could be an essential advance for CBD and the battle against antimicrobial resistance. Component CBD continues to have an excellent safety profile and is ruled out toxic even in big amounts. Luckily, Dr. Blaskovich and his group plan to continue their research study.

Scroll to top